SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-107390
Filing Date
2016-06-08
Accepted
2016-06-08 08:25:26
Documents
2
Period of Report
2016-06-06
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v441969_8k.htm 8-K 39023
2 EXHIBIT 99.1 v441969_ex99-1.htm EX-99.1 7856
  Complete submission text file 0001144204-16-107390.txt   48594
Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120
Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 161702716
SIC: 2836 Biological Products, (No Diagnostic Substances)